Do analysts recommend BIRD or VIVO?

VivoPower PLC Ordinary Shares has a consensus target price of $10.00, indicating a potential upside of 158.40%. Given VivoPower PLC Ordinary Shares' stronger consensus rating and higher possible upside, analysts clearly believe VivoPower PLC Ordinary Shares is more favorable than Allbirds. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allbirds 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 VivoPower PLC Ordinary Shares 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation & earnings, BIRD or VIVO?

VivoPower PLC Ordinary Shares has lower revenue, but higher earnings than Allbirds. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Allbirds $152.47M 0.14 -$77.28M -$8.99 N/A VivoPower PLC Ordinary Shares $60K 808.19 -$12.79M N/A N/A

Do analysts recommend VVPR or BIRD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivopower International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Allbirds 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has stronger earnings and valuation, VVPR or BIRD?

Vivopower International has higher earnings, but lower revenue than Allbirds. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vivopower International $61K 819.39 -$12.79M N/A N/A Allbirds $152.47M 0.14 -$77.28M -$8.99 N/A

Do analysts recommend BIRD or POAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allbirds 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Predictive Oncology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer IPM or BIRD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Protection Management 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Allbirds 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts recommend ALP or BIRD?

Portage Biotech presently has a consensus target price of $12.50, indicating a potential upside of 207.13%. Given Portage Biotech's stronger consensus rating and higher possible upside, equities analysts clearly believe Portage Biotech is more favorable than Allbirds. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Allbirds 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Allbirds (BIRD) Competitors

$2.48 +0.05 (+1.84%)

As of 11:19 AM Eastern

Compare

BIRD vs. VIVO, VVPR, POAI, IPM, and ALP

Should you buy Allbirds stock or one of its competitors? Allbirds's main competitors and comparable companies include VivoPower PLC Ordinary Shares (VIVO), Vivopower International (VVPR), Predictive Oncology (POAI), Intelligent Protection Management (IPM), and Portage Biotech (ALP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "internet services & infrastructure" industry.

How does Allbirds compare to VivoPower PLC Ordinary Shares?

Allbirds (NASDAQ:BIRD) and VivoPower PLC Ordinary Shares (NASDAQ:VIVO) are both small-cap technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.

VivoPower PLC Ordinary Shares has a net margin of 0.00% compared to Allbirds' net margin of -72.82%. VivoPower PLC Ordinary Shares' return on equity of 0.00% beat Allbirds' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allbirds	-72.82%	-231.86%	-81.53%
VivoPower PLC Ordinary Shares	N/A	N/A	N/A

In the previous week, VivoPower PLC Ordinary Shares had 1 more articles in the media than Allbirds. MarketBeat recorded 2 mentions for VivoPower PLC Ordinary Shares and 1 mentions for Allbirds. Allbirds' average media sentiment score of 1.87 beat VivoPower PLC Ordinary Shares' score of 1.29 indicating that Allbirds is being referred to more favorably in the media.

Company	Overall Sentiment
Allbirds	Very Positive
VivoPower PLC Ordinary Shares	Positive

Allbirds has a beta of 2.62, meaning that its stock price is 162% more volatile than the broader market. Comparatively, VivoPower PLC Ordinary Shares has a beta of -0.65, meaning that its stock price is 165% less volatile than the broader market.

VivoPower PLC Ordinary Shares has lower revenue, but higher earnings than Allbirds.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allbirds	$152.47M	0.14	-$77.28M	-$8.99	N/A
VivoPower PLC Ordinary Shares	$60K	808.19	-$12.79M	N/A	N/A

44.1% of Allbirds shares are owned by institutional investors. Comparatively, 15.8% of VivoPower PLC Ordinary Shares shares are owned by institutional investors. 18.8% of Allbirds shares are owned by company insiders. Comparatively, 9.1% of VivoPower PLC Ordinary Shares shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

VivoPower PLC Ordinary Shares has a consensus target price of $10.00, indicating a potential upside of 158.40%. Given VivoPower PLC Ordinary Shares' stronger consensus rating and higher possible upside, analysts clearly believe VivoPower PLC Ordinary Shares is more favorable than Allbirds.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allbirds	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
VivoPower PLC Ordinary Shares	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

VivoPower PLC Ordinary Shares beats Allbirds on 9 of the 14 factors compared between the two stocks.

How does Allbirds compare to Vivopower International?

Vivopower International (NASDAQ:VVPR) and Allbirds (NASDAQ:BIRD) are both small-cap technology companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

Vivopower International has higher earnings, but lower revenue than Allbirds.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivopower International	$61K	819.39	-$12.79M	N/A	N/A
Allbirds	$152.47M	0.14	-$77.28M	-$8.99	N/A

Vivopower International has a net margin of 0.00% compared to Allbirds' net margin of -72.82%. Vivopower International's return on equity of 0.00% beat Allbirds' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivopower International	N/A	N/A	N/A
Allbirds	-72.82%	-231.86%	-81.53%

Vivopower International has a beta of -1.65, suggesting that its stock price is 265% less volatile than the broader market. Comparatively, Allbirds has a beta of 2.62, suggesting that its stock price is 162% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivopower International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Allbirds	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

15.8% of Vivopower International shares are owned by institutional investors. Comparatively, 44.1% of Allbirds shares are owned by institutional investors. 9.1% of Vivopower International shares are owned by company insiders. Comparatively, 18.8% of Allbirds shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Allbirds had 1 more articles in the media than Vivopower International. MarketBeat recorded 1 mentions for Allbirds and 0 mentions for Vivopower International. Allbirds' average media sentiment score of 1.87 beat Vivopower International's score of 0.00 indicating that Allbirds is being referred to more favorably in the news media.

Company	Overall Sentiment
Vivopower International	Neutral
Allbirds	Very Positive

Summary

Allbirds beats Vivopower International on 7 of the 12 factors compared between the two stocks.

How does Allbirds compare to Predictive Oncology?

Allbirds (NASDAQ:BIRD) and Predictive Oncology (NASDAQ:POAI) are both small-cap technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

44.1% of Allbirds shares are held by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are held by institutional investors. 18.8% of Allbirds shares are held by company insiders. Comparatively, 1.2% of Predictive Oncology shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Allbirds has a beta of 2.62, meaning that its share price is 162% more volatile than the broader market. Comparatively, Predictive Oncology has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market.

In the previous week, Allbirds had 1 more articles in the media than Predictive Oncology. MarketBeat recorded 1 mentions for Allbirds and 0 mentions for Predictive Oncology. Allbirds' average media sentiment score of 1.87 beat Predictive Oncology's score of 0.00 indicating that Allbirds is being referred to more favorably in the media.

Company	Overall Sentiment
Allbirds	Very Positive
Predictive Oncology	Neutral

Predictive Oncology has lower revenue, but higher earnings than Allbirds. Predictive Oncology is trading at a lower price-to-earnings ratio than Allbirds, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allbirds	$152.47M	0.14	-$77.28M	-$8.99	N/A
Predictive Oncology	$1.66M	22.78	-$12.66M	-$13.50	N/A

Allbirds has a net margin of -72.82% compared to Predictive Oncology's net margin of -5,065.23%. Allbirds' return on equity of -231.86% beat Predictive Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allbirds	-72.82%	-231.86%	-81.53%
Predictive Oncology	-5,065.23%	-732.73%	-235.55%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allbirds	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Allbirds beats Predictive Oncology on 12 of the 14 factors compared between the two stocks.

How does Allbirds compare to Intelligent Protection Management?

Intelligent Protection Management (NASDAQ:IPM) and Allbirds (NASDAQ:BIRD) are both small-cap technology companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations.

Intelligent Protection Management has a beta of 0.46, indicating that its stock price is 54% less volatile than the broader market. Comparatively, Allbirds has a beta of 2.62, indicating that its stock price is 162% more volatile than the broader market.

3.9% of Intelligent Protection Management shares are owned by institutional investors. Comparatively, 44.1% of Allbirds shares are owned by institutional investors. 20.8% of Intelligent Protection Management shares are owned by company insiders. Comparatively, 18.8% of Allbirds shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Intelligent Protection Management has a net margin of -14.80% compared to Allbirds' net margin of -72.82%. Intelligent Protection Management's return on equity of -21.13% beat Allbirds' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Protection Management	-14.80%	-21.13%	-13.41%
Allbirds	-72.82%	-231.86%	-81.53%

Intelligent Protection Management has higher earnings, but lower revenue than Allbirds. Intelligent Protection Management is trading at a lower price-to-earnings ratio than Allbirds, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Protection Management	$23.61M	0.71	-$1.96M	-$0.28	N/A
Allbirds	$152.47M	0.14	-$77.28M	-$8.99	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Protection Management	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Allbirds	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Intelligent Protection Management had 1 more articles in the media than Allbirds. MarketBeat recorded 2 mentions for Intelligent Protection Management and 1 mentions for Allbirds. Allbirds' average media sentiment score of 1.87 beat Intelligent Protection Management's score of 0.86 indicating that Allbirds is being referred to more favorably in the news media.

Company	Overall Sentiment
Intelligent Protection Management	Positive
Allbirds	Very Positive

Summary

Intelligent Protection Management beats Allbirds on 8 of the 13 factors compared between the two stocks.

How does Allbirds compare to Portage Biotech?

Portage Biotech (NASDAQ:ALP) and Allbirds (NASDAQ:BIRD) are both small-cap technology companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends.

In the previous week, Portage Biotech had 10 more articles in the media than Allbirds. MarketBeat recorded 11 mentions for Portage Biotech and 1 mentions for Allbirds. Allbirds' average media sentiment score of 1.87 beat Portage Biotech's score of 0.21 indicating that Allbirds is being referred to more favorably in the news media.

Company	Overall Sentiment
Portage Biotech	Neutral
Allbirds	Very Positive

Portage Biotech has higher earnings, but lower revenue than Allbirds. Portage Biotech is trading at a lower price-to-earnings ratio than Allbirds, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$100K	63.09	-$38.63M	-$8.18	N/A
Allbirds	$152.47M	0.14	-$77.28M	-$8.99	N/A

Portage Biotech has a net margin of 0.00% compared to Allbirds' net margin of -72.82%. Portage Biotech's return on equity of 0.00% beat Allbirds' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Allbirds	-72.82%	-231.86%	-81.53%

13.4% of Portage Biotech shares are owned by institutional investors. Comparatively, 44.1% of Allbirds shares are owned by institutional investors. 18.8% of Allbirds shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Portage Biotech has a beta of 0.54, indicating that its share price is 46% less volatile than the broader market. Comparatively, Allbirds has a beta of 2.62, indicating that its share price is 162% more volatile than the broader market.

Portage Biotech presently has a consensus target price of $12.50, indicating a potential upside of 207.13%. Given Portage Biotech's stronger consensus rating and higher possible upside, equities analysts clearly believe Portage Biotech is more favorable than Allbirds.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Allbirds	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Portage Biotech beats Allbirds on 9 of the 15 factors compared between the two stocks.

Get Allbirds News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BIRD vs. The Competition

Export

Metric	Allbirds	IT Services Industry	Technology Sector	NASDAQ Exchange
Market Cap	$21.68M	$10.80B	$29.25B	$12.73B
Dividend Yield	N/A	2.83%	2.74%	11.71%
P/E Ratio	-0.27	14.22	76.48	25.33
Price / Sales	0.14	69.93	591.42	90.47
Price / Cash	N/A	44.33	46.59	34.96
Price / Book	0.60	8.27	7.69	6.23
Net Income	-$77.28M	$271.17M	$703.70M	$358.31M
7 Day Performance	-2.42%	-1.64%	-1.76%	-1.45%
1 Month Performance	-3.57%	-4.27%	-4.47%	-2.79%
1 Year Performance	-59.89%	22.61%	178.72%	8.30%

Allbirds Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BIRD Allbirds	1.3857 of 5 stars	$2.49 +1.8%	N/A	-60.2%	$21.89M	$152.47M	N/A	710	Positive News
VIVO VivoPower PLC Ordinary Shares	1.7316 of 5 stars	$4.15 +6.7%	$10.00 +141.0%	N/A	$52M	$60K	N/A	41
VVPR Vivopower International	0.008 of 5 stars	$3.89 -0.8%	N/A	-21.9%	$48.73M	$61K	N/A	240	Gap Up
POAI Predictive Oncology	0.047 of 5 stars	$10.67 +8.0%	N/A	-21.6%	$36.21M	$1.66M	N/A	30
IPM Intelligent Protection Management	2.0376 of 5 stars	$1.94 +1.6%	N/A	-2.1%	$17.53M	$25.19M	N/A	20	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BIRD) was last updated on 9/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Allbirds (BIRD) Competitors

BIRD vs. VIVO, VVPR, POAI, IPM, and ALP

How does Allbirds compare to VivoPower PLC Ordinary Shares?

Summary

How does Allbirds compare to Vivopower International?

Summary

How does Allbirds compare to Predictive Oncology?

Summary

How does Allbirds compare to Intelligent Protection Management?

Summary

How does Allbirds compare to Portage Biotech?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIRD vs. The Competition

Allbirds Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Allbirds (BIRD) Competitors

BIRD vs. VIVO, VVPR, POAI, IPM, and ALP

How does Allbirds compare to VivoPower PLC Ordinary Shares?

Is BIRD or VIVO more profitable?

Does the media favor BIRD or VIVO?

Which has more volatility & risk, BIRD or VIVO?

Which has stronger valuation & earnings, BIRD or VIVO?

Do insiders & institutionals believe in BIRD or VIVO?

Do analysts recommend BIRD or VIVO?

Summary

How does Allbirds compare to Vivopower International?

Which has stronger earnings and valuation, VVPR or BIRD?

Is VVPR or BIRD more profitable?

Which has more volatility and risk, VVPR or BIRD?

Do analysts recommend VVPR or BIRD?

Do institutionals and insiders have more ownership in VVPR or BIRD?

Does the media refer more to VVPR or BIRD?

Summary

How does Allbirds compare to Predictive Oncology?

Do institutionals and insiders hold more shares of BIRD or POAI?

Which has more volatility and risk, BIRD or POAI?

Does the media prefer BIRD or POAI?

Which has better earnings and valuation, BIRD or POAI?

Is BIRD or POAI more profitable?

Do analysts recommend BIRD or POAI?

Summary

How does Allbirds compare to Intelligent Protection Management?

Which has more risk and volatility, IPM or BIRD?

Do institutionals and insiders hold more shares of IPM or BIRD?

Is IPM or BIRD more profitable?

Which has higher valuation and earnings, IPM or BIRD?

Do analysts prefer IPM or BIRD?

Does the media refer more to IPM or BIRD?

Summary

How does Allbirds compare to Portage Biotech?

Does the media favor ALP or BIRD?

Which has preferable earnings and valuation, ALP or BIRD?

Is ALP or BIRD more profitable?

Do insiders & institutionals believe in ALP or BIRD?

Which has more volatility & risk, ALP or BIRD?

Do analysts recommend ALP or BIRD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIRD vs. The Competition

Allbirds Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools